Loading...
•
Mar 31, 2021
Sotera Health Q1 2021 Earnings Report
Sotera Health's first quarter of 2021 resulted in double-digit revenue growth, meaningful net income growth, and double-digit Adjusted EBITDA growth.
Key Takeaways
Sotera Health reported a strong start to 2021 with double-digit revenue and Adjusted EBITDA growth. Net revenues for Q1 2021 increased by 13% to $212 million, and net income was $11 million, or $0.04 per diluted share. The company reaffirmed its 2021 outlook.
Q1 2021 net revenues increased 13% to $212 million compared to Q1 2020.
Q1 2021 net income was $11 million, or $0.04 per diluted share, compared to a net loss of $2 million in Q1 2020.
Q1 2021 Adjusted EPS increased 80% to $0.18, compared to $0.10 in Q1 2020.
The company reaffirmed its 2021 outlook.
Revenue by Segment
Forward Guidance
Sotera Health reaffirmed its 2021 outlook, which was first provided on March 9, 2021.
Positive Outlook
- Net revenues in the range of $890 million to $920 million, representing growth of approximately 9% to 12%, compared to the prior year.
- Adjusted EBITDA in the range of $465 million to $485 million, representing growth of approximately 11% to 16%, compared to the prior year.
- Tax rate applicable to Adjusted Net Income of approximately 28%.
- Adjusted EPS in the range of $0.78 to $0.86.
- Net leverage reduction of approximately 3⁄4 of a turn.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...